Novartis reported 8.65B in Trade Debtors for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Debtors Change
Amgen AMGN:US $ 4479M 56M
AstraZeneca AZN:LN 6.84B 214M
Bayer BAYN:GR 15.8B 97M
Biogen BIIB:US $ 2110.2M 113.9M
Bristol Myers Squibb BMY:US $ 11275M 2615M
Eli Lilly And LLY:US $ 6902.8M 244.2M
Fresenius FRE:GR € 7497M 279M
Galapagos GLPG:NA 113.6M 66.75M
Genmab GEN:DC 2.43B 575M
Gilead Sciences GILD:US $ 4149M 224M
GlaxoSmithKline GSK:LN 7.51B 324M
GRIFOLS GRF:SM € 644.7M 148.92M
H. Lundbeck A/S LUN:DC 3.86B 6M
Hikma Pharmaceutical HIK:LN 780M 46M
Merck MRK:GR € 4124M 102M
Novartis NOVN:VX 8.65B 173M
Novartis NVS:US $ 8654M 173M
Orion ORNBV:FH 184.2M 16.6M
Recordati REC:IM 357.26M 14.14M
Regeneron Pharmaceuticals REGN:US $ 6998.6M 2825.6M